XSTO
HEGR
Market cap1mUSD
Oct 06, Last price
0.44SEK
1D
0.00%
1Q
-8.75%
Jan 2017
-97.53%
IPO
-96.56%
Name
Hedera Group AB (publ)
Chart & performance
P/E
—
P/S
0.03
EPS
—
Div yield, %
45.66%
Shrs. gr., 5y
22.18%
Rev. gr., 5y
18.82%
Revenues
516m
-4.97%
Net income
-9m
L+273.76%
CFO
-3m
L
Dividend
May 10, 20240.2 SEK/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hedera Group AB (publ) and its affiliated entities operate within Sweden, providing specialized human resources for the healthcare sector. Their primary focus is on the recruitment and placement of physicians and registered nurses into various medical settings, including primary care centers, municipal health services, and hospitals across the country. Beyond these core staffing solutions, the firm also offers expert consulting. Hedera Group AB (publ) maintains its main operational hub in Stockholm, Sweden, and functions as a subsidiary of Bertil Haglund med bolag.
Related entities
Subsidiaries
Svensk lakartjanst LIL AB
Key people
Malin Falconer
Chief Executive Officer · since 2026
Maria Isendahl
Chief Financial Officer · since 2025
Azim Fatan
Chief Executive Officer of Lakarresurs FA Rekryt AB · since 2015
Christer Ryder
Vice President Hedera Group, Business Area Manager Hedera Assistance · since 2019
Lisa Lund
Human Resources Director · since 2021
Risto Urdzanov
Operational manager LILAB and Hedera Medical and Hedera Nurse · since 2022
Ingrid Nordlund
Director · since 2026
Johan Sandstrom
Chief Executive Officer, Director · since 2020
Stig Engcrantz
Independent Director · since 2019
Bertil Haglund
Independent Non-Executive Chairman of the Board · since 2018
Headquarters & legal address
Vasagatan 15-17
STOCKHOLM 111 20
SE
STOCKHOLM 111 20
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||